【ChiCTR2200065425】The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risks older adults in Hong Kong: a pilot study

查看原文

立即下载

基本信息

登记号

ChiCTR2200065425

试验状态

正在进行

药物名称

药物类型

规范名称

首次公示信息日的期

2022-11-04

临床申请受理号

靶点

适应症

Colorectal cancer

试验通俗题目

The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risks older adults in Hong Kong: a pilot study

试验专业题目

The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risks older adults in Hong Kong: a pilot study

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

Phase 1 1. Develop a training program for lay navigators in facilitating CRC screening uptake. 2. Evaluate the effectiveness of the training program in improving the knowledge of CRC of the lay navigators by completing pretest and posttest related to the CRC knowledge. 3. Evaluate the self-efficacy of lay navigators in providing PN intervention by completing pretest and posttest of self-efficacy scale. 4. Evaluate the satisfaction of the program by the lay navigators after training. Phase 2 1. Develop and implement an evidenced-based PN intervention to enhance the uptake of CRC screening for the average risk of older adults in Hong Kong. 2. Evaluate the feasibility and acceptability of PN intervention by assessing the screening rate, recruitment rate, percentage of eligibility, consent rate, withdrawal rate during recruitment, attrition rate of the participants and satisfaction rate of the participants. 3. Evaluate the preliminary effect of the PN intervention by the uptake rate of the CRC screening of the average risk older adults compared to control arm at baseline and 3 months after the intervention. 4. Determine the preliminary effects of PN intervention on knowledge, perceived susceptibility, severity, benefits and barriers on CRC screening.

试验分类

请登录查看

试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

For the recruited 60 participants, they will be randomly allocated to one of the two arms by using computer-generated randomization scheme: 30 participants will be allocated to an intervention arm that will be given lay navigator intervention. 30 participants will be allocated to wait list control arm.

盲法

The participants will be blinded for the allocation of intervention or control group.

试验项目经费来源

Hong Kong Metropolitan University

试验范围

目标入组人数

实际入组人数

第一例入组时间

2022-11-09

试验终止时间

2023-06-30

是否属于一致性

入选标准

Phase 1 1. Older adults aged 50-75 years; 2. Speak fluent Cantonese; 3. Education level up to secondary school to facilitate the delivery of the CRC information; 4. Have experience in CRC screening by using FOBT/FIT; 5. Willing to complete the training programme and act as lay navigator for the target participants. Phase 2 1. Average-risk older adults who age 50 -75 will be recruited as participants in this study; 2. He/She should have no history of CRC, no chronic inflammation of the bowel, no first-degree relatives having CRC and have never screened for CRC.；

排除标准

1. Have mental and cognitive problems; 2. Prior CRC cancer.；

研究者信息

研究负责人姓名

请登录查看

试验机构

Hong Kong Metropolitan University

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编